Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-arm, Multi-Center, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Melphalan/HDS Treatment in Patients With Hepatic-Dominant Ocular Melanoma

NCT02678572 is registered in ClinicalTrials.gov with Delcath Systems Inc. as lead sponsor.

NCT NCT02678572
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02678572 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-arm, Multi-Center, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Melphalan/HDS Treatment in Patients With Hepatic-Dominant Ocular Melanoma
Lead sponsor
Delcath Systems Inc.
Phase
Phase 3
Overall status
Completed
Start date
February 1, 2016
Completion date
August 15, 2023
Enrollment
102 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

ocular melanoma, uveal melanoma